Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
S N Liossis, … , G J Dennis, G C Tsokos
S N Liossis, … , G J Dennis, G C Tsokos
Published April 1, 1998
Citation Information: J Clin Invest. 1998;101(7):1448-1457. https://doi.org/10.1172/JCI1457.
View: Text | PDF
Research Article Article has an altmetric score of 6

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.

  • Text
  • PDF
Abstract

Cellular immunity aberrations in patients with SLE are underscored by the abnormal early Ag receptor-mediated lymphocyte signal transduction pathway. To further characterize the T cell receptor (TCR)/CD3-initiated signaling defects, we studied 22 patients with SLE, 12 patients with other systemic rheumatic diseases, and 14 normal donors. The early (1 min) TCR/CD3-mediated tyrosine phosphorylation of cellular proteins with a molecular size between 36 and 64 kD was increased in 15 of 21 SLE patients, compared to normal or disease control subjects. The deficiency or absence of a band with a molecular size of approximately 16 kD in the immunoblots of SLE patients led us to investigate the expression of the TCRzeta chain. In immunoblots using anti-zeta antibodies we found that 10 of 22 lupus patients tested lacked the expression of TCRzeta, which was always present in control subjects (P < 0.001). Flow cytometric studies using permeabilized cells confirmed the deficiency or absence of the TCRzeta chain in lupus T cells. Using Northern blots we found that for eight patients tested, the TCRzeta mRNA was missing in three, decreased in three, and apparently normal in two patients (P < 0.003), but was always present in control subjects. Reverse transcriptase-PCR verified Northern blot results. We conclude that TCRzeta chain expression is either decreased or absent in the majority of patients with SLE, but not in patients with other systemic rheumatic diseases, regardless of disease activity, treatment status, or clinical manifestations. The previously described increases in TCR-initiated Ca2+ responses and the herein described increases in TCR-induced protein tyrosine phosphorylation and deficient TCRzeta expression may represent intrinsic defects modulating lupus T cell function.

Authors

S N Liossis, X Z Ding, G J Dennis, G C Tsokos

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1991 Total
Citations: 2 7 4 4 2 1 3 8 4 6 5 6 12 11 14 16 8 10 11 15 15 23 19 13 18 13 3 8 1 262
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2004 (23)

Title and authors Publication Year
Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus
S Krishnan, MP Nambiar, VG Warke, CU Fisher, J Mitchell, N Delaney, GC Tsokos
Journal of immunology (Baltimore, Md. : 1950) 2004
Targeting CD40L: a promising therapeutic approach
D Daoussis, AP Andonopoulos, SN Liossis
Clinical and diagnostic laboratory immunology 2004
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity
A Perl, P Gergely, G Nagy, A Koncz, K Banki
Trends in Immunology 2004
DISSECTING THE MOLECULAR MECHANISMS OF TCR ζ CHAIN DOWNREGULATION AND T Cell SIGNALING ABNORMALITIES IN HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS
MP Nambiar, YT Juang, S Krishnan, GC Tsokos
International Reviews of Immunology 2004
Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: Molecular and functional analysis
J Otsuka, T Horiuchi, S Yoshizawa, H Tsukamoto, T Sawabe, Y Kikuchi, D Himeji, T Koyama, H Mitoma, T Watanabe, M Harada
Arthritis & Rheumatism 2004
DECREASED T CELL ERK PATHWAY SIGNALING MAY CONTRIBUTE TO THE DEVELOPMENT OF LUPUS THROUGH EFFECTS ON DNA METHYLATION AND GENE EXPRESSION
K Oelke, B Richardson
International Reviews of Immunology 2004
ALTERED EXPRESSION OF THE T CELL RECEPTOR-CD3 COMPLEX IN SYSTEMIC LUPUS ERYTHEMATOSUS
T Takeuchi, K Tsuzaka, T Abe
International Reviews of Immunology 2004
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
M Baniyash
Nature Reviews Immunology 2004
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha
JM Clark, AE Annenkov, M Panesar, P Isomäki, Y Chernajovsky, AP Cope
Proceedings of the National Academy of Sciences 2004
MITOCHONDRIAL DYSFUNCTION IN T CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
A Perl, P Gergely, K Banki
International Reviews of Immunology 2004
l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytes
AH Zea, PC Rodriguez, KS Culotta, CP Hernandez, J DeSalvo, JB Ochoa, HJ Park, J Zabaleta, AC Ochoa
Cellular Immunology 2004
Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients
A Maki, M Matsuda, M Asakawa, H Kono, H Fujii, Y Matsumoto
Journal of Gastroenterology and Hepatology 2004
T lymphocytes in systemic lupus erythematosus: an update
VC Kyttaris, GC Tsokos
Current Opinion in Rheumatology 2004
Masking of the CD3γ di-Leucine-based Motif by ζ is Required for Efficient T-Cell Receptor Expression
JP Lauritsen, CM Bonefeld, M Essen, MW Nielsen, AB Rasmussen, N Ødum, J Dietrich, C Geisler
Traffic 2004
Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice
D Sun, A Krishnan, J Su, R Lawrence, K Zaman, G Fernandes
Cellular Immunology 2004
T lymphocytes in systemic lupus erythematosus: an update:
VC Kyttaris, GC Tsokos
Current Opinion in Rheumatology 2004
Costimulation Blockade in the Treatment of Rheumatic Diseases:
SN Liossis, PP Sfikakis
BioDrugs 2004
Infection and Autoimmunity
C Dugué, Y Renaudineau, P Youinou
Infection and Autoimmunity 2004
Principles of Gender-Specific Medicine
G Supinski, LA Callahan
Principles of Gender-Specific Medicine 2004
ALTERED SIGNALING TRIGGERED BY LIGATION OF THE TCR/CD3 RECEPTOR IN T LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE ROAD FROM ANERGY TO AUTOIMMUNITY
AM Blasini, MA RODRíGUEZ
International Reviews of Immunology 2004
Decreased Expression of the CD3ζ Chain in T Cells Infiltrating the Synovial Membrane of Patients with Osteoarthritis
LI Sakkas, G Koussidis, E Avgerinos, J Gaughan, CD Platsoucas
Clinical and vaccine immunology : CVI 2004
T-cell receptor–induced phosphorylation of the ζ chain is efficiently promoted by ZAP-70 but not Syk
M Steinberg, O Adjali, L Swainson, P Merida, VD Bartolo, L Pelletier, N Taylor, N Noraz
Blood 2004
Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?
Whiteside TL
Cancer Immunology, Immunotherapy 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 1 Wikipedia pages
45 readers on Mendeley
See more details